Monday, November 18, 2024
Home Blog Page 3156

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Blue Ridge Bankshares, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – BRBS

Hong Kong Baptist University-led research discovers new therapeutic target for irritable bowel syndrome

New York, New York – Newsfile Corp. – December 9, 2023 – WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Blue Ridge Bankshares, Inc. (NYSE American: BRBS) between March 10, 2023 and October 31, 2023, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 5, 2024 in the securities class action first filed by the Firm.

SO WHAT: If you purchased Blue Ridge securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Blue Ridge class action, go to https://rosenlegal.com/submit-form/?case_id=20587 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 5, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Blue Ridge Bankshares, Inc.’s financial statements from March 10, 2023 to the present included certain errors; (2) as a result, Blue Ridge Bankshares would need to restate its previously filed financial statements from March 10, 2023 to October 31, 2023; and (3) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Blue Ridge class action, go to https://rosenlegal.com/submit-form/?case_id=20587 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com

The issuer is solely responsible for the content of this announcement.

Source link

This content was prepared by Media OutReach. The opinions expressed in this article are the author's own and do not reflect the view of Siam News Network.

ROSEN, A RANKED AND LEADING FIRM, Encourages ACELYRIN, INC. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SLRN

Hong Kong Baptist University-led research discovers new therapeutic target for irritable bowel syndrome

New York, New York – Newsfile Corp. – December 9, 2023 – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11, 2023, both dates inclusive (the “Class Period”), of the important January 16, 2024 lead plaintiff deadline.

SO WHAT: If you purchased ACELYRIN securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the ACELYRIN class action, go to https://rosenlegal.com/submit-form/?case_id=20478 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 16, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) izokibep was less effective in treating Hidradenitis Suppurativa (“HS”) than defendants had led investors to believe; (2) accordingly, ACELYRIN overstated izokibep’s clinical and/or commercial prospects; (3) as a result, ACELYRIN also overstated the Company’s business prospects post-IPO; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the ACELYRIN class action, go to https://rosenlegal.com/submit-form/?case_id=20478 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com

The issuer is solely responsible for the content of this announcement.

Source link

This content was prepared by Media OutReach. The opinions expressed in this article are the author's own and do not reflect the view of Siam News Network.

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AdaptHealth Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AHCO

Hong Kong Baptist University-led research discovers new therapeutic target for irritable bowel syndrome

New York, New York – Newsfile Corp. – December 9, 2023 – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of AdaptHealth Corp. (NASDAQ: AHCO) between (1) August 4, 2020 and February 27, 2023, both dates inclusive (the “Class Period”) and/or (2) AdaptHealth common stock pursuant and/or traceable to the Company’s secondary public offering (the “SPO”) conducted on or around January 5, 2021, of the important December 26, 2023 lead plaintiff deadline.

SO WHAT: If you purchased AdaptHealth common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the AdaptHealth class action, go to https://rosenlegal.com/submit-form/?case_id=20167 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 26, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements because: (1) AdaptHealth misstated the Company’s true ability to generate organic growth in its diabetes segment; (2) AdaptHealth engaged in improper upcoding and other illicit billing practices; and (3) as a result of the foregoing, certain of the defendants’ statements about AdaptHealth’s business, operations and prospects were materially misleading and/or lacked a reasonable basis.

Further, the lawsuit alleges the “SPO Offering Materials contained untrue statements of material fact, omitted material facts necessary to make the statements contained therein not misleading, and failed to make adequate disclosures required under the rules and regulations governing the preparation of such documents.” When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the AdaptHealth class action, go to https://rosenlegal.com/submit-form/?case_id=20167 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com

The issuer is solely responsible for the content of this announcement.

Source link

This content was prepared by Media OutReach. The opinions expressed in this article are the author's own and do not reflect the view of Siam News Network.

GAABOR LAUNCHES YEAR END SALE 12.12 VAGANZA

0

JAKARTA, Indonesia, Dec. 10, 2023 /PRNewswire/ — Gaabor, as a leading household appliance brand in Southeast Asia, always wants to provide an interesting experience with each of its quality products. Join and make life easier with more than one million Indonesians.

To complete the range of promotions at this 12.12 shopping party, Gaabor is also providing attractive promotions through superior products such as the Airfryer (AF20M), this Airfryer with a 2 liter capacity provides practicality and ease of cooking without oil, apart from that Gaabor also presents an electric kettle (EK20M-WH02A) able to provide the hot water quickly and save energy, and to complete the cleaning needs in the residence, Gaabor also provides a promo for a vacuum cleaner product (VCW14M-BE01A) to make it easier for customers to clean their favorite room.

This December, in conjunction with the 12.12 campaign, Gaabor is providing discount promos of up to millions of rupiah, additional vouchers and attractive prizes for customers to add to cart only for the period 12 to 15 December 2023.

This is the opportunity can’t be missed to own Gaabor at an affordable price and stunning quality. Get it only on the favorite online platforms.

Source : GAABOR LAUNCHES YEAR END SALE 12.12 VAGANZA

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

Thailand Steps Up Efforts to Combat Counterfeit Goods

0
img-slide

Thailand is taking strong measures to combat counterfeit products online, safeguarding property rights and reputation. Efforts include raising awareness, enforcing intellectual property rights, and forming partnerships with online platforms.

Thailand’s Efforts Against Counterfeit Products

Thailand is ramping up its efforts to combat the production and distribution of counterfeit goods, which pose a serious threat to the country’s economy, public health, and reputation. The government has launched a campaign to raise awareness about the dangers of buying and selling fake products and to encourage reporting of suspicious activities.

Combatting Counterfeit Products

Commerce Minister Phumtham Wechayachai is taking action against the sale of counterfeit branded products online to protect Thailand’s international reputation. The Department of Intellectual Property (DIP) is educating SMEs about the significance of patenting their products, while also promoting the production and recognition of geographical indication (GI) products.

Partnerships and Agreements

DIP announced an upcoming memorandum of understanding between copyright owners and leading online platforms. This agreement will strengthen the fight against piracy, and the DIP is also collaborating with Facebook to develop tools for identifying and removing counterfeit products and copyright violations on the platform.

Source : Thailand Steps Up Efforts to Combat Counterfeit Goods

Neusoft Education Technology Group was Selected into the "2023 Typical Cases of Brand Credit Construction" by Xinhua News Agency

0

HONG KONG, Dec. 9, 2023 /PRNewswire/ — By the riverside of Wanquan, a forum was held in Boao. From 2nd of December to 5th of December 2023, the 2023 Boao Forum for Chinese Entrepreneurs under the theme of "Embracing the Innovation with a Focus on Quality" organized by Xinhua News Agency, the People’s Government of Hainan Province and the China Council for Brand Development was held in Boao, Hainan Province, with more than 3,500 guests from the Fortune Global 500, Top 500 Enterprises of China and industry-leading enterprises gathered together. At the "2023 Xinhua Brand Credit Construction Forum" held on 4th of December, the list of "2023 Typical Cases of Brand Credit Construction" was released for the first time. Neusoft Education Technology Group was successfully selected with its brand construction case, which is a full recognition for its demonstration and leading role in the "China Digital Talent Education Service Brand" industry and the achievements of its distinctive brand construction practices.

Credit is the lifeblood of a brand, and the high-quality development of Chinese brands relies on the brand credit construction by enterprises. In March 2022, the Opinions on Promoting the Construction of a Social Credit System with High-quality Development and Promoting the Formation of a New Development Landscape issued by the General Office of the CPC Central Committee and the General Office of the State Council proposed the promotion of quality and brand credit construction. Based on this background, to better construct the corporate brand credit system, enhance the value of enterprise brand credit, and support the cultivation of a large number of exemplary enterprises that operate with integrity and fulfill their commitments, Xinhua News Agency launched the activity of "2023 Collection of Typical Cases of Brand Credit Construction", aiming to exert the demonstration and leading effects of advanced models, drive the collective creation, construction and sharing of a brand credit system throughout society, empower enterprises to develop with high quality, and serve the strategy for a strong brand nation.  

As a leading IT higher education technology group and digital talent education service provider in China, Neusoft Education Technology Group focuses on the field of "IT + Health technology", forming a business development ecosystem consisting of higher education, education resources and continuing education services, known as the "One Fundamental Business and Two Strategic Businesses" model. Leveraging its strong industrial advantages and accumulated experience in academic education, and guided by the characteristic TOPCARES education methodology and talent training model, Neusoft developed an innovative "4S" System (CaaS – Content as a Service, SaaS – Software as a Service, PaaS – Platform as a Service, DaaS – Data as a Service) product service system, in a bid to empower comprehensive and three-dimensional connotation construction of education and teaching as well as reform and innovation in colleges and universities. So far, Neusoft Education provides high-quality educational resources, products and services to over 550 colleges and universities in China. In addition, in terms of continuing education services, To B training business has expanded to 24 provinces and cities across the country, and To C training business attracted more than 15,000 trainees annually. The above-mentioned data performance and educational service achievements serve as strong evidence of the industry influence, brand appeal and social credibility of Neusoft Education Technology Group.

Looking ahead, Neusoft Education Technology Group will seize this award as an opportunity to actively play an exemplary role in the industry in digital education service brand, and continuously promote sustainable and high-quality development of the brand, making contributions to the construction of a digital China and the cultivation of digital talents.

Media Contact:

Lin Wei
[email protected] 
+852 69969328

Source : Neusoft Education Technology Group was Selected into the "2023 Typical Cases of Brand Credit Construction" by Xinhua News Agency

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

WANTIFO Launches Hair Dryer DualCare with Advanced Plasma Ionic Tech

0

NEW YORK, Dec. 9, 2023 /PRNewswire/ — Wantifo, leading the beauty tech industry, introduces the WANTIFO Hair Dryer DualCare, now available on Amazon.US. Known for blending high-tech solutions with user-friendly designs, WANTIFO’s latest offering, the DualCare, epitomizes their commitment to accessible, sophisticated beauty tools.

The WANTIFO Hair Dryer DualCare, boasting a high-speed 110,000 RPM brushless motor and cutting-edge Plasma Ionic Technology, emits 200 million positive and negative ions. This feature not only improves scalp health but also reduces hair loss and curbs frizz, resulting in softer, healthier, and more lustrous hair.

Efficient by design, the WANTIFO Hair Dryer DualCare ensures quick drying without heat damage. It includes customizable temperature settings, three distinct heat and speed options, and an HD LCD for user-friendly operation. Its 360° magnetic nozzle caters to different hair types and lengths, making it a versatile tool for any hair care routine.

Weighing just 0.82 pounds and maintaining a noise level under 60dB, the DualCare is perfect for home and travel use. It’s built with safety in mind, featuring a UL-certified US ALCI safety plug, automatic protection mechanisms, and an easy-to-use auto-cleaning function.

Experience the DualCare difference with an exclusive 30% off. Use code "30WANTIFO" at here.

For more information on the DualCare Hair Dryer, please contact:

Marketing Manager: Annie Hatfield
Email: [email protected]
Official Website: https://wantifo.com/
Amazon Store: https://www.amazon.com/stores/WAINTIFOISWONDERFUL/page/8BB8E322-FBEA-4027-AEE0-CBE5B723D1F0?ref_=ast_bln
Social Medias: https://linktr.ee/wantifo

About WANTIFO

WANTIFO, a dynamic brand in the haircare industry, focuses on efficient, damage-free drying and stylish functionality, revolutionizing daily hair routines.

 

 

Source : WANTIFO Launches Hair Dryer DualCare with Advanced Plasma Ionic Tech

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

WuXi Biologics Awarded Highest Platinum Medal by EcoVadis Sustainability Rating

0

Ranked in top 1% of the over 100,000 companies evaluated Recognized for outstanding performance across all areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement Seen as a trusted partner by global clients for its strong sustainability commitment

SHANGHAI, Dec. 8, 2023 /PRNewswire/ — WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has been awarded the EcoVadis Sustainability Rating’s Platinum Medal, the highest level of recognition granted to the companies being evaluated.

EcoVadis is a leading ratings organization for the sustainability of supply chains. Businesses of all sizes rely on EcoVadis’ expert intelligence and evidence-based ratings to improve the sustainability performance of their companies and their value chains. As a result of WuXi Biologics’ outstanding performance across four core themes – Environment, Labor & Human Rights, Ethics, and Sustainable Procurement – it was ranked in the top 1% of the more than 100,000 companies evaluated worldwide.

Dr. Chris Chen, WuXi Biologics CEO and Chairman of the ESG Committee, commented, "We are very proud to receive the Platinum Medal from EcoVadis, which we see as a strong testament to our sustainable business strategy. The EcoVadis Sustainability Rating is an important reference for our partners worldwide – notably all the global pharmaceutical companies – in evaluating sustainability performance and the benefits of collaboration. We will continue to work with clients, suppliers, employees and other stakeholders to enhance our ESG capabilities and advance the common good of the global community."

The EcoVadis recognition follows other notable WuXi Biologics ESG achievements this year. In June, it signed the Science Based Targets initiative (SBTi) commitment letter, a new milestone towards the goal of net-zero. In September, the company became a signatory to the United Nations Global Compact, demonstrating its sustainability commitment. In November, it received an AAA rating from MSCI ESG Ratings.

About WuXi Biologics

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.

With over 12,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As of June 30, 2023, WuXi Biologics is supporting 621 integrated client projects, including 22 in commercial manufacturing.

WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of our ethos and business strategy, and we aim to become an ESG leader in the biologics CRDMO sector. Our facilities use next-generation biomanufacturing technologies and clean-energy sources. We have also established an ESG committee led by our CEO to steer the comprehensive ESG strategy and its implementation, enhancing our commitment to sustainability.

For more information about WuXi Biologics, please visit: www.wuxibiologics.com.

Contacts
ESG
[email protected]

Media
[email protected]

Source : WuXi Biologics Awarded Highest Platinum Medal by EcoVadis Sustainability Rating

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network